PharmaResearch stock price

파마리서치KRX:214450 · KOSDAQ · Healthcare · sector #23
₩301,500-2.27%
2026-10-08 close
Loading chart…

PharmaResearch's chart data is dated 2026-10-08. There is no active technical signal. There are 4 published signal records.

PharmaResearch last closed at ₩301,500 (-2.27%) on 2026-10-08. Listed on KOSDAQ. Trailing 12 months PER is 16.9×. Its overall grade ranks 100 of 308 stocks in Healthcare.

About this company

PharmaResearch last closed at ₩301,500 (-2.27%) on 2026-10-08. Listed on KOSDAQ.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall B+ · 100/308

Valuation grade F

Details →

Dividends

2025 dividend per share · ₩1,100 · Yield 1.21%

Details →

Recent filings

DART · received recent list, not a complete filing history. Factual information, not investment advice.

Details →

Related stocks

  • 메디톡스Competitor

    국내 보툴리눔 톡신·미용의료 시장에서 경쟁

  • 휴젤Competitor

    미용의료/에스테틱 시술 시장의 국내 경쟁사

  • 대웅제약Competitor

    톡신·에스테틱 영역에서 사업 중복 및 경쟁

Details →

ETFs holding this stock

TIGER 의료기기 · SOL 의료기기소부장Fn · HANARO K-뷰티

Details →
About PharmaResearch
What technical signals does PharmaResearch (214450) have?
PharmaResearch current technical signals: no active technical signal.
Is PharmaResearch a cup-and-handle pattern?
No. PharmaResearch has no valid Cup signal right now.
What published figures are available for PharmaResearch?
Market cap: KRW 3.1T. Trailing 12 months PER: 16.9×. Latest quarter PBR: 4.17×. Dividend yield: 1.21%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Major stocks in the same sector

2026-10-09 dataset

Turn what you saw on this name into a strategy

Ask Q about PharmaResearch, or open the plan table on the main site.

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

PharmaResearch notifications

Quantus Signal · live data · not investment advice · Privacy Policy